EXPAND Study on Ultra-Rare Cholestatic Liver Disease @checkrare
EXPAND Study on Ultra-Rare Cholestatic Liver Disease  @checkrare
Uploaded November 2026 | Updated November 2026, 15 hours ago
What were the results from the EXPAND clinical trial of maralixibat in patients with ultra-rare cholestatic liver diseases?

View the full interview at checkrare.com/mirums-livmarli-achieves-primary-endpoint-in-phase-3-expand-study
EXPAND Study on Ultra-Rare Cholestatic Liver DiseaseThe Role of Rusfertide in Decreasing Phlebotomies in Patients With Polycythemia VeraFDA Approves New Narcolepsy TreatmentEfficacy of Infigratinib on AchondroplasiaMogamulizumab in Danish Patients With CTCLHow Bispecific Antibodies Are Changing Multiple Myeloma TreatmentThe Need for Earlier Pulmonary Hypertension Screening in Interstitial Lung DiseaseThe Need for Earlier Pulmonary Hypertension Screening in Interstitial Lung DiseaseFabry Disease: Patients Real-World Problems and How to ManageLipodystrophy Research Presented at ENDO 2026Diagnosis and Treatment of IGF-1 DeficiencyPhase 2a GATEWAY Trial of PORT-77 in Patients With Erythropoietic Protoporphyria Shows Promise
CheckRare |

EXPAND Study on Ultra-Rare Cholestatic Liver Disease

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER